Aktuellt
SENASTE
Redeye endorses aXichem’s new order of USD280,000 from Iovate. The order is the first within the two companies' research, development and commercialization agreement, with a total estimated value of USD5m over the next three years. We are currently reviewing our long-term take on the case with a more conservative stance and will return with a new Base Case shortly.
LÄS MER
